Hybrigenics SA, together with its subsidiaries, operates as a biotechnology company in France. The company engages in development of biotechnology in the field of biotechnology, oncology, regenerative medicine, and anti-aging medicine. It is also involved in the development of technical solutions using adipose tissue cells and stem cells. The company is headquartered in Gallargues-le-Montueux, France. Hybrigenics SA is a subsidiary of Diagnostic Medical Systems S.A.
Research context
Hybrigenics Société Anonyme appears in PyInvesting’s Paris Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Apr 1, 2021
Hybrigenics Société Anonyme is currently in a long term downtrend where the price is trading 26.4% below its 200 day moving average.
From a valuation standpoint, the stock is 14.4% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 312.8.
Based on the above factors, Hybrigenics Société Anonyme gets an overall score of 0/5.